The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2019

Filed:

Feb. 12, 2016
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Carolyn Ruth Bertozzi, Berkeley, CA (US);

Nicholas J. Agard, Berkeley, CA (US);

Jennifer A. Prescher, Berkeley, CA (US);

Jeremy Michael Baskin, Berkeley, CA (US);

Ellen May Sletten, Berkeley, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/655 (2006.01); C07C 45/29 (2006.01); C07C 45/51 (2006.01); C07C 45/63 (2006.01); C07C 49/497 (2006.01); C07C 49/753 (2006.01); C07C 59/72 (2006.01); C07C 63/66 (2006.01); C07C 63/74 (2006.01); C07C 69/708 (2006.01); C07C 69/76 (2006.01); C07C 57/26 (2006.01); C07D 207/416 (2006.01); C07D 207/452 (2006.01); C07D 249/16 (2006.01); C07D 495/04 (2006.01); C07C 49/457 (2006.01); G01N 33/531 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/655 (2013.01); C07C 45/292 (2013.01); C07C 45/511 (2013.01); C07C 45/63 (2013.01); C07C 49/457 (2013.01); C07C 49/753 (2013.01); C07C 57/26 (2013.01); C07C 59/72 (2013.01); C07C 63/66 (2013.01); C07C 63/74 (2013.01); C07C 69/708 (2013.01); C07C 69/76 (2013.01); C07D 207/416 (2013.01); C07D 207/452 (2013.01); C07D 249/16 (2013.01); C07D 495/04 (2013.01); G01N 33/531 (2013.01); G01N 33/6803 (2013.01); G01N 33/6842 (2013.01); C07C 2601/18 (2017.05);
Abstract

The present invention provides modified cycloalkyne compounds; and method of use of such compounds in modifying biomolecules. The present invention features a cycloaddition reaction that can be carried out under physiological conditions. In general, the invention involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).


Find Patent Forward Citations

Loading…